Comment intégrer l'imagerie moderne dans le diagnostic précoce et le suivi de la spondylarthrite ankylosante ? = Optimized use of cross-sectional imaging for the early diagnosis and management of ankylosing spondyloarthropathyKEMTA LEKPA, F; LENCZNER, G; FARRENQ, V et al.Journal de radiologie (Paris). 2010, Vol 91, Num 1, pp 162-172, issn 0221-0363, 11 p., CAH2Article

Intérêt du rituximab dans le traitement du lupus érythémateux systémique = Therapeutic value of rituximab in the management of systemic lupusKEMTA LEKPA, F; MARINI, A; CLAUDEPIERRE, P et al.La Lettre du rhumatologue. 2008, Num 340, pp 12-14, issn 0761-5027, 3 p.Article

Acute myeloid leukemia after infliximab: a case reportKEMTA LEKPA, F; ZAHRA, K; PAUTAS, C et al.Clinical and experimental rheumatology (Testo stampato). 2009, Vol 27, Num 6, pp 999-1000, issn 0392-856X, 2 p.Article

Serum cartilage oligomeric matrix protein (COMP) level is a marker of disease activity in relapsing polychondritisKEMTA LEKPA, F; PIETTE, J. C; BASTUJI-GARIN, S et al.Clinical and experimental rheumatology (Testo stampato). 2010, Vol 28, Num 4, pp 553-555, issn 0392-856X, 3 p.Article

Prevalence and Factors Associated With Uveitis in Spondylarthritis Patients in France: Results From an Observational SurveyCANOUÏ-POITRINE, F; KEMTA LEKPA, F; FARRENQ, V et al.Arthritis care and research. 2012, Vol 64, Num 6, pp 919-924, issn 0893-7524, 6 p.Article